Molecular Pharmacology (USA) Ltd. engages in the development of pharmaceutical products. It discovers and develops analgesic and anti-inflammatory products based on the proprietary MPL-TL compound. The MPL-TL compound is an oligopeptide which is a new key active ingredient that targets a different part of the pain and inflammation cascade than other analgesic and anti-inflammatory drugs. The company was founded on May 1, 2002 and is headquartered in Stroudsburg, PA.
公司网站 :
-
总经理:Xin Shi
建立时间:2002
公司总部:Stroudsburg
领域:Commercial services
行业:Miscellaneous commercial services